New pill aims to steady shaking hands in essential tremor trial
NCT ID NCT06087276
First seen Jun 27, 2026 · Last updated Jul 17, 2026 · Updated 2 times
Summary
This study tests whether a new drug called ulixacaltamide can safely reduce tremors and improve daily activities in adults with essential tremor. About 1,000 participants will receive either the drug or a placebo for up to 12 weeks, then may join a long-term safety study. The goal is to see if the drug helps with tasks like eating and writing.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESSENTIAL TREMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
United BioSource LLC
Morgantown, West Virginia, 26508, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can MRI reveal the Brain's response to deep brain stimulation?
- Can home brain recordings Fine-Tune deep brain stimulation for tremor?
- Brain surgery meets brain science: probing how a memory-related chemical system influences cognition
- Can deep brain stimulation rewire faulty movement circuits? a surgery-time study aims to find out.
- Zapping away tremors: scientists probe how electrical stimulation calms shaky hands
- Could gentle electrical pulses steady shaky hands?